The Biosimilar Toolbox: How To Ratchet Up Biosimilar Competition In 2021

Biosimilar Development is happy to usher in the new year with its third installment of the Editorial Board Q&A series. As you’ll read in the following responses, increased competition in 2021 is on the minds of many. Whether that competition is unlocked thanks to shared savings models, employer biosimilar initiatives, new/multiple product launches, and/or regulatory evolution, we just have to wait and see. But if one thing is clear, it’s that the industry has many exciting tools on the line that are worth watching as 2021 unfolds.

Reunión Virtual